Millions of Brits ‘should get Ozempic to slash their chances of heart attack and stroke’: Major study hails slimming jabs as biggest breakthrough since statins because drugs cut risk even in patients who don’t lose weight [Video]

18:00 EDT 13 May 2024, updated 07:26 EDT 14 May 2024

Millions of Britons should be prescribed weight-loss jabs to slash their chances of heart attack and stroke, cardiologists said yesterday.

The biggest study yet on Ozempic and Wegovy found their key ingredient was a ‘game-changer’ for heart patients, including those who did not lose weight.

It found the weekly shot cut by a fifth their risk of further heart attacks or death. Britain’s top cardiologist said it was the most significant development in heart disease since statins in the 1990s and would ‘change clinical practice’.

John Deanfield of University College London said the study proved semaglutide was more than an obesity drug because it ‘targets the underlying biology of chronic diseases’.

The findings suggest it could be used to treat everything from cancer to kidney disease.